CytomX Therapeutics, Inc. (CTMX)
$2.57+4.05%Close
SELLCRISIS · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $413M
- Beta
- 2.20
- P/E (TTM)
- -5.69
- Short % float
- 29.17%
- Days to cover
- 8.7
- SI change
- +5.6%
- 1W
- +0.39%
- 1M
- -23.28%
- vs SPY 1W
- -0.77%
- vs SPY 1M
- -26.28%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CTMX?
- LOPJLB’s latest quantitative signal on CytomX Therapeutics, Inc. (CTMX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CTMX in?
- CytomX Therapeutics, Inc. (CTMX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does CytomX Therapeutics, Inc. (CTMX) do?
- CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications. Its robust clinical pipeline includes several notable drug candidates. CX-2009, an antibody-drug conjugate (ADC) designed to targ…